Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection in Blood of Autoantibodies to Tumour Antigens as a Case-finding Method in Lung Cancer Using the EarlyCDT-Lung Test

NCT01925625 is registered in ClinicalTrials.gov with Stuart Schembri as lead sponsor.

NCT NCT01925625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection in Blood of Autoantibodies to Tumour Antigens as a Case-finding Method in Lung Cancer Using the EarlyCDT-Lung Test
Lead sponsor
Stuart Schembri
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2013
Completion date
August 31, 2018
Enrollment
12,210 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer